Aurora Cannabis Inc.

Aurora Cannabis Inc.

Aurora Cannabis Inc. is a world-renowned integrated cannabis company with an industry-leading reputation for continuously elevating and setting the global cannabis industry standard.
Medical Marijuana State Programs
Company Details
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Canada
Summary
Fiscal year-end
June 30
Headquarters
Vancouver, BC
Number of Patients
67,484 at 9/30/18
Financials (Pro Forma 6/30)
Cash on hand
$147.8mm
Fixed investment
$449.9mm
Shareholders’ equity
$4.40 billion
Revenues – last quarter
$29.7mm
Adj. gross margin
67.8%
EPS
$0.12
Capital Structure
Capital structure
11/09/18
Last financing
Last Equity Fin $345mm Convertible Notes at US$7.23
Basic shares
965.1mm
Warrants
22.6mm
Options
42.2mm
Diluted shares
1049.6mm

Aurora Cannabis Inc. News

25 Jun

CbdMD Teams Up With Bellator MMA To 'Educate Athletes And Fans' About CBD

As part of the agreement, mixed martial arts organization Bellator MMA will give cbdMD exclusive branding rights inside the Bellator cage. CbdMD president Caryn Dunayer said in the press release the partnership...

24 Jun

Aurora Cannabis in 5 Charts

Here’s a quick overview of the marijuana star's key business drivers.

24 Jun

Aurora Cannabis Could Be One of the First Marijuana Sellers to Turn a Profit

Aurora Cannabis is on track to be the one of the first big marijuana firms to turn a profit. That could come as soon as this quarter, a top pot analyst said.

24 Jun

Cowen: Aurora Is 'Top Pick In Cannabis'

Several Wall Street analysts have come out bullish on cannabis stocks in recent months, but one analyst said Monday that Aurora Cannabis Inc (NYSE: ACB ) is the clear top choice in the sector.  The Analyst...

24 Jun

Aurora Cannabis Could be Among the First Marijuana Sellers to Turn a Profit

Canada’s Aurora Cannabis is on track to be the one of the first big marijuana firms to turn a profit. That could come as soon as this quarter, according to Cowen analyst Vivien Azer.

24 Jun

The 10 Most Important Numbers in Canopy Growth's Fourth-Quarter Report

When the biggest pot stock in the world releases its operating results, you best pay attention.

23 Jun

3 Potential Catalysts That Could Cause Aurora Cannabis Stock to Skyrocket

The chances for at least a couple of these catalysts happening appear to be really good.

21 Jun

Aurora Cannabis Confirms Plans For Consumer Products In Canada

Aurora said it will produce new, high-quality products for sale in the Canadian market. Ahead of the product launch, the cannabis company secured supply agreements with cannabis consumer technology brand...

21 Jun

Aurora Cannabis Prepared for Expansion of Canada's Cannabis Market

EDMONTON, June 21, 2019 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (ACB) (ACB), the Canadian company defining the future of cannabis worldwide, today announced its plans for the highly-anticipated...

21 Jun

5 Things to Watch With Aurora Cannabis for the Remainder of 2019

The most popular pot stock has a number of lingering questions that investors want answered.

Load more

About Aurora Cannabis Inc.

Aurora is one of the world’s largest and fastest growing cannabis companies. Following the acquisition of MedReleaf, the company has more than 1,500 employees, 11 facilities, and a funded annual production capacity of more than 500,000 kilograms per year. The Company is vertically integrated and horizontally diversified across every key segment of the cannabis value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis, and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company’s purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. Aurora’s growing constellation of subsidiaries and strategic partnerships provide differentiation in terms of geographic reach, production, technology, product offering, and execution.

With a growing number of countries adopting medical cannabis legislation, the Company has embarked on an aggressive international expansion strategy that currently sees Aurora with operations and/or sales in 22 countries across five continents.

"Through our wholly owned subsidiaries, strategic investments, and global partnerships, Aurora provides a wide range of premium quality cannabis and hemp products and services, develops innovative technologies, promotes cannabis consumer health and wellness, and delivers an exceptional customer experience across all its brands.

Aurora’s operations span multiple continents and focuses on both the medical and recreational cannabis production and sales, patient education and clinic counselling services, home hydroponic cultivation, extraction technologies and delivery systems, and hemp-based food health products.

We operate around the globe pursuing new and emerging cannabis markets where possible through our owned network of import, export and wholesale distributors, and our e-commerce and mobile applications."

Corporate Governance

Aurora Cannabis Inc.’s ISS Governance QualityScore as of January 28, 2019 is 10. The pillar scores are Audit: 2; Board: 10; Shareholder Rights: 9; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Features Aurora Cannabis Inc.

Canadian Operations

  • Multiple state-of-the-art facilities in operation or under construction in four provinces
  • Recent acquisitions of CanniMed and MedReleaf leave the company with nine facilities in Canada
  • Ownership of CanvasRx, the largest operator of cannabis clinics in Canada with 35 clinics open
  • Strong product portfolio with Aurora, CanniMed, and MedReleaf brands and wellness brands including San Rafael ’71, Woodstock, and AltaVie
  • Same-day delivery in Alberta and innovative mobile ordering app
  • Supply agreements with 12 provinces and territories
  • Agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart to distribute and sell medical cannabis
  • 40 clinical studies completed or ongoing
  • Large investment portfolio including TGOD, Radient Technologies, Hempco, Alcanna (formerly Liquor Stores N.A.), and more

Global Operations

  • Active in five continents and 22 countries
  • 22.9% ownership of Australia’s Cann Group (ASX: CAN)
  • 51% ownership of Aurora Nordic in Denmark
  • Ownership of German distribution company Pedanios
  • Wholly owned subsidiary ICC Labs gives the company a platform in Latin America
  • Acquired European hemp company Agropro and sister company Borela
  •  Supply agreements in Italy, South Africa, Luxembourg, and Mexico
  • Import permit from the Polish Ministry of Health
  • Approved for the first cannabis cultivation facility in Malta
  • Structured investment in spin-off Australis Capital, which positions the company to benefit from eventual U.S. legalization

Team

Terry Booth
Founder, CEO
Mr. Stephen Dobler
Founder, Pres & Director
Glen Ibbott
Chief Financial Officer

Participation in events

Jobs

Position
City
Type
Salary
Posted
CITY:
Markham Ontario, Canada
TYPE:
Full-Time
SALARY:
DOE
POSTED:
30 Sep 2019
CITY:
Edmonton Alberta, Canada
TYPE:
Full-Time
SALARY:
DOE
POSTED:
31 Mar 2019
CITY:
Medicine Hat Alberta, Canada
TYPE:
Full-Time
SALARY:
DOE
POSTED:
12 Feb 2019
$ 2.64
12.82%
Open:
2.41
High:
2.73
Low:
2.36
Share volume:
9.684 M
Total value:
56.912 M
Market cap:
6.05 B
Symbol:
ACB

Hours (MST)

Mon
6:00 - 18:00
Tue
6:00 - 18:00
Wed
6:00 - 18:00
Thu
6:00 - 18:00

Open now

Fri
6:00 - 18:00